Skip to Main Content

Paper Details

Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
Biol Blood Marrow Transplant
19
2019
CH50, Eculizumab, TA-TMA, TMA, Thrombotic Microangiopathy, Transplantation-associated thrombotic microangiopathy, cancer, carboplatin, children, chronic kidney disease, eculizumab, etoposide, hematopoietic cell, hypertension, melphalan, multiorgan failure, nephrotic range, nephrotic range proteinuria, neuroblastoma, organ dysfunction, patients, proteinuria, relapsed, renal involvement, sC59-b and, sc5b-9, stem cell
Author NameAffiliation
Leslie Lehmann
Clement MaBoston Children's Hospital
  • 1 - 2

Datasets

Release 1.2